{"id":"W2588845480","doi":"10.1093/annonc/mdw379.46","title":"Evaluation of the pharmacokinetic (PK) profile of vismodegib (VISMO) in patients (pts) with multiple basal cell carcinomas (BCCs) across two intermittent treatment regimens in the MIKIE study","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"Saint Louis University","keywords":"Medicine; Regimen; Vismodegib; Placebo; Population; Internal medicine; Dosing; Urology; Clinical endpoint; Pharmacokinetics; Basal cell carcinoma; Randomized controlled trial; Gastroenterology; Surgery; Basal cell; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001149838,0.000394469,0.0008568869,0.0002150296,0.0002169998,0.0006853447,0.0003125065,0.0003440198,0.00152144],"category_scores_gemma":[0.001535984,0.0002619282,0.0006709913,0.0003086978,0.0003035731,0.0007655049,0.0003222272,0.001047545,0.0002633638],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007071192,"about_ca_system_score_gemma":0.0005260006,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006160318,"about_ca_topic_score_gemma":0.001166491,"domain_scores_codex":[0.9995341,0.0001852465,0.00002838656,0.0001118225,0.00008179124,0.00005876091],"domain_scores_gemma":[0.999406,0.0001415682,0.000165763,0.00008787728,0.00004025852,0.0001585597],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5098266,0.009482911,0.2363357,0.0003753051,0.00322473,0.0002063075,0.0004369075,0.003466108,0.08114695,0.0003278999,0.0013357,0.1538349],"study_design_scores_gemma":[0.0351614,0.2654399,0.6709201,0.00004101815,0.003146027,0.0007889263,0.0003153583,0.004178559,0.01337078,0.0003141612,0.006237166,0.0000866378],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987795,0.0003459379,0.0001498344,0.00003149342,0.000005967132,0.00006478981,0.000210512,0.000007633017,0.0004043652],"genre_scores_gemma":[0.9984838,0.000203879,0.0002830903,0.00006501516,0.00001748103,0.00008765992,0.0004530142,0.000008399543,0.000397627],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00152144,"threshold_uncertainty_score":0.006080985,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08781250879323721,"score_gpt":0.3857656443177965,"score_spread":0.2979531355245593,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}